SQUAWK/NEWS
Account
Theme
Account
Menu
Live News REGULATION FLASH L impact

China’s NMPA reviews Innovent’s sintilimab combination for advanced melanoma

Valid market news retained in the public archive without immediate LiveCast distribution.

Related stories